136 related articles for article (PubMed ID: 22155625)
1. Inhibitory effects of C4a on chemoattractant and secretagogue functions of the other anaphylatoxins via Gi protein-adenylyl cyclase inhibition pathway in mast cells.
Xie P; Nishiura H; Semba U; Chen J; Zhao R; Kuniyasu A; Yamamoto T
Int Immunopharmacol; 2012 Jan; 12(1):158-68. PubMed ID: 22155625
[TBL] [Abstract][Full Text] [Related]
2. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.
Nilsson G; Johnell M; Hammer CH; Tiffany HL; Nilsson K; Metcalfe DD; Siegbahn A; Murphy PM
J Immunol; 1996 Aug; 157(4):1693-8. PubMed ID: 8759757
[TBL] [Abstract][Full Text] [Related]
3. Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1.
Legler DF; Loetscher M; Jones SA; Dahinden CA; Arock M; Moser B
Eur J Immunol; 1996 Apr; 26(4):753-8. PubMed ID: 8625964
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of type II adenylyl cyclase by chemoattractant formyl peptide and C5a receptors.
Tsu RC; Allen RA; Wong YH
Mol Pharmacol; 1995 Apr; 47(4):835-41. PubMed ID: 7723745
[TBL] [Abstract][Full Text] [Related]
5. The role of the ribosomal protein S19 C-terminus in Gi protein-dependent alternative activation of p38 MAP kinase via the C5a receptor in HMC-1 cells.
Nishiura H; Tokita K; Li Y; Harada K; Woodruff TM; Taylor SM; Nsiama TK; Nishino N; Yamamoto T
Apoptosis; 2010 Aug; 15(8):966-81. PubMed ID: 20473571
[TBL] [Abstract][Full Text] [Related]
6. Mast cells are not required for anaphylatoxin-induced ileal smooth muscle contraction.
Stimler-Gerard NP; Galli SJ
J Immunol; 1987 Mar; 138(6):1908-13. PubMed ID: 2434565
[TBL] [Abstract][Full Text] [Related]
7. The human chemoattractant complement C5a receptor inhibits cyclic AMP accumulation through Gi and Gz proteins.
Shum JK; Allen RA; Wong YH
Biochem Biophys Res Commun; 1995 Mar; 208(1):223-9. PubMed ID: 7887933
[TBL] [Abstract][Full Text] [Related]
8. C3a and C5a stimulate chemotaxis of human mast cells.
Hartmann K; Henz BM; Krüger-Krasagakes S; Köhl J; Burger R; Guhl S; Haase I; Lippert U; Zuberbier T
Blood; 1997 Apr; 89(8):2863-70. PubMed ID: 9108406
[TBL] [Abstract][Full Text] [Related]
9. Carbachol-induced decrease in thyroid cell adenylyl cyclase activity is independent of calcium and phosphodiesterase activation.
Pasquali D; Rani CS; Deery WJ
Mol Pharmacol; 1992 Jan; 41(1):163-7. PubMed ID: 1310140
[TBL] [Abstract][Full Text] [Related]
10. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
[TBL] [Abstract][Full Text] [Related]
11. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation.
Schraufstatter IU; Discipio RG; Zhao M; Khaldoyanidi SK
J Immunol; 2009 Mar; 182(6):3827-36. PubMed ID: 19265162
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II-evoked enhanced expression of RGS2 attenuates Gi-mediated adenylyl cyclase signaling in A10 cells.
Li Y; Hashim S; Anand-Srivastava MB
Cardiovasc Res; 2005 Jun; 66(3):503-11. PubMed ID: 15914115
[TBL] [Abstract][Full Text] [Related]
14. The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a.
Hugli TE
Crit Rev Immunol; 1981 Feb; 1(4):321-66. PubMed ID: 7037298
[No Abstract] [Full Text] [Related]
15. F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins.
Basta M; Van Goor F; Luccioli S; Billings EM; Vortmeyer AO; Baranyi L; Szebeni J; Alving CR; Carroll MC; Berkower I; Stojilkovic SS; Metcalfe DD
Nat Med; 2003 Apr; 9(4):431-8. PubMed ID: 12612546
[TBL] [Abstract][Full Text] [Related]
16. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells.
el-Lati SG; Dahinden CA; Church MK
J Invest Dermatol; 1994 May; 102(5):803-6. PubMed ID: 7513741
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide modulates Gi-protein expression and adenylyl cyclase signaling in vascular smooth muscle cells.
Bassil M; Anand-Srivastava MB
Free Radic Biol Med; 2006 Oct; 41(7):1162-73. PubMed ID: 16962941
[TBL] [Abstract][Full Text] [Related]
18. Dopamine stimulates 45Ca2+ uptake through cAMP, PLC/PKC, and MAPKs in renal proximal tubule cells.
Han JY; Heo JS; Lee YJ; Lee JH; Taub M; Han HJ
J Cell Physiol; 2007 May; 211(2):486-94. PubMed ID: 17167784
[TBL] [Abstract][Full Text] [Related]
19. Modulation of G-protein expression and adenylyl cyclase signaling by high glucose in vascular smooth muscle.
Hashim S; Li Y; Nagakura A; Takeo S; Anand-Srivastava MB
Cardiovasc Res; 2004 Sep; 63(4):709-18. PubMed ID: 15306227
[TBL] [Abstract][Full Text] [Related]
20. Enzymatic regulation of mast cell activation and secretion by adenylate cyclase and cyclic AMP-dependent protein kinases.
Winslow CM; Austen KF
Fed Proc; 1982 Jan; 41(1):22-9. PubMed ID: 6173264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
